Answers are grounded in this paper and cite their sources.
Bioactive constituents of Morus alba were evaluated for inhibition of nitric oxide (NO) production, α-glucosidase, and protein tyrosine phosphatase 1B (PTP1B). Seven compounds were isolated and structurally elucidated by nuclear magnetic resonance spectroscopy, with compounds 3–6 reported for the first time from this species. ε-Viniferin (3) most strongly inhibited lipopolysaccharide-induced NO production (IC50 = 2.8 μM). Mulberrofuran G (7) showed the greatest α-glucosidase (IC50 = 2.1 μM) and PTP1B (IC50 = 1.12 μM) inhibition and was more potent than ursolic acid against PTP1B. Compounds 1, 3, 5, and 7 were active in all three assays. Docking indicated favourable interactions with the selected inflammatory and metabolic targets, highlighting M. alba metabolites as promising multifunctional scaffolds with anti-inflammatory and metabolic enzyme inhibitory potential, warranting further mechanistic studies.
No takes yet. Share an insight, caveat, or question.
Hoang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: